ATE342511T1 - Methode zur in vivo identifizierung von intrazellularen epitopen - Google Patents

Methode zur in vivo identifizierung von intrazellularen epitopen

Info

Publication number
ATE342511T1
ATE342511T1 AT01983776T AT01983776T ATE342511T1 AT E342511 T1 ATE342511 T1 AT E342511T1 AT 01983776 T AT01983776 T AT 01983776T AT 01983776 T AT01983776 T AT 01983776T AT E342511 T1 ATE342511 T1 AT E342511T1
Authority
AT
Austria
Prior art keywords
peptide
recognise
molecule
cells
vivo identification
Prior art date
Application number
AT01983776T
Other languages
English (en)
Inventor
Antonino Cattaneo
Michela Visintin
Original Assignee
S I S S A Scuola Internaz Supe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I S S A Scuola Internaz Supe filed Critical S I S S A Scuola Internaz Supe
Application granted granted Critical
Publication of ATE342511T1 publication Critical patent/ATE342511T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01983776T 2000-10-24 2001-10-22 Methode zur in vivo identifizierung von intrazellularen epitopen ATE342511T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000561A IT1317922B1 (it) 2000-10-24 2000-10-24 Metodo per identificare in vivo epitopi intracellulari.

Publications (1)

Publication Number Publication Date
ATE342511T1 true ATE342511T1 (de) 2006-11-15

Family

ID=11454967

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01983776T ATE342511T1 (de) 2000-10-24 2001-10-22 Methode zur in vivo identifizierung von intrazellularen epitopen

Country Status (12)

Country Link
US (1) US20030235850A1 (de)
EP (1) EP1328814B1 (de)
JP (1) JP2004512529A (de)
AT (1) ATE342511T1 (de)
AU (1) AU2002215194A1 (de)
CA (1) CA2426744A1 (de)
DE (1) DE60123819T2 (de)
DK (1) DK1328814T3 (de)
ES (1) ES2272553T3 (de)
IT (1) IT1317922B1 (de)
PT (1) PT1328814E (de)
WO (1) WO2002035237A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799535B1 (en) 1997-12-09 2010-09-21 Arch Development Corporation Methods for identifying factors that control the folding of amyloid proteins of diverse origin
US7045290B2 (en) 2001-02-15 2006-05-16 The University Of Chicago Yeast screens for treatment of human disease
WO2012162179A1 (en) * 2011-05-20 2012-11-29 Oligomerix, Inc. Tau protease compositions and methods of use
WO2013063613A2 (en) * 2011-10-28 2013-05-02 University Of Maryland Methods and compositions related to intracellular neutralization by igg
HRP20201914T1 (hr) 2013-05-06 2021-01-22 Scholar Rock, Inc. Sastavi i postupci za modulaciju faktora rasta
MX2017006167A (es) 2014-11-12 2018-03-23 Siamab Therapeutics Inc Compuestos que interactúan con glicanos y métodos de uso.
ITUB20155272A1 (it) 2015-11-02 2017-05-02 Scuola Normale Superiore Intracellular antibody
CA3002097A1 (en) 2015-11-12 2017-05-18 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
KR20240044544A (ko) 2017-03-03 2024-04-04 씨젠 인크. 글리칸-상호작용 화합물 및 사용 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2344886B (en) * 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins
EP1479694B1 (de) * 1999-12-28 2016-10-26 ESBATech, an Alcon Biomedical Research Unit LLC ScFv Intrakörper mit definierter Struktur ("Framework"), der in einer reduzierenden Umgebung stabil ist

Also Published As

Publication number Publication date
ITRM20000561A1 (it) 2002-04-24
AU2002215194A1 (en) 2002-05-06
WO2002035237A3 (en) 2002-10-10
JP2004512529A (ja) 2004-04-22
PT1328814E (pt) 2007-01-31
ITRM20000561A0 (it) 2000-10-24
EP1328814A2 (de) 2003-07-23
US20030235850A1 (en) 2003-12-25
ES2272553T3 (es) 2007-05-01
EP1328814B1 (de) 2006-10-11
WO2002035237A2 (en) 2002-05-02
DE60123819D1 (de) 2006-11-23
IT1317922B1 (it) 2003-07-15
CA2426744A1 (en) 2002-05-02
DK1328814T3 (da) 2007-01-29
DE60123819T2 (de) 2007-08-02

Similar Documents

Publication Publication Date Title
PH12021553042A1 (en) Sorting with counter selection using sequence similar peptides
WO2002020569A3 (en) Mammalian genes; related reagents and methods
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DE60310562D1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
IL188554A0 (en) Novel phage display technologies
DE60123819D1 (de) Methode zur in vivo identifizierung von intrazellularen epitopen
IL273648B1 (en) Microbiota sequence variants of tumor-related antigenic epitopes
DK0500659T3 (da) Monoklonale antistoffer.
AU1172202A (en) Far red shifted fluorescent proteins
NZ547629A (en) Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
RU94046414A (ru) Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
EA200600738A1 (ru) Способ
AP2368A (en) Novel expression vectors and uses thereof.
ATE327251T1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
WO2002068459A3 (en) Non aggregating fluorescent proteins and methods for using the same
DE69533504D1 (de) Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
DE69836647D1 (de) Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 'large' t antigen mit einem intakten n terminus
WO2005058362A3 (en) Method for opening tight junctions comprising the use of jam-1, claudin-4 and occludin protein antagonists as well as sirna molecules
RU2004118303A (ru) Быстросозревающие флуоресцирующие белки и способы их применения
DE60025522D1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
WO2002059309A3 (en) Anthozoa derived chromoproteins, fluorescent mutants thereof and methods for using the same
WO2004056316A8 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
WO2000055192A3 (de) Hämocyanin und dafür kodierende nukleinsäuresequenz
WO2002061389A3 (en) Methods to generate and identify monoclonal antibodies to a large number of human antigens
Stec Sindbis virus antigenic structure and variation.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1328814

Country of ref document: EP

REN Ceased due to non-payment of the annual fee